Full name
ANGIODIABETICA KLINIKA CHORÓB NACZYŃ I STOPY CUKRZYCOWEJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
ANGIODIABETICA KLINIKA CHORÓB NACZYŃ I STOPY CUKRZYCOWEJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. PRZEMYSŁOWA 46A / U3, 61-541 POZNAŃ
TAX ID7831730928
Rate company:
ANGIODIABETICA KLINIKA CHORÓB NACZYŃ I STOPY CUKRZYCOWEJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7831730928
KRS0000577462
Share capital66,000.00 zł
address
UL. PRZEMYSŁOWA 46A / U3, 61-541 POZNAŃ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7831730928
REGON
362565581
KRS
0000577462
Legal form
limited liability company
Register Address
UL. PRZEMYSŁOWA 46A / U3, 61-541 POZNAŃ
Date of registration in KRS
2015-09-24
Date of commencement of economic activity
2015-09-24
Act signature
PO.VIII NS-REJ.KRS/27101/22/21/ADE
Pkd codes
86.22.Z - Specialist medical practice
47.74.Z - Retail sale of medical and orthopedic products
72.19.Z - Scientific research and development activities
85 - Education
86.90.C - Healthcare
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL91 1090 1476 0000 0001 3151 4746 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,2 | 0,1 | -0,1 | -271,7 |
Gross profit (loss) | 0,2 | 0,1 | -0 | -167,7 |
EBITDA | 0,3 | 0,1 | 0 | -71,7 |
Short time liabilities | 0,3 | 0,3 | 0,3 | 19,6 |
Other operating costs | 0 | 0 | 0 | -33,2 |
Equity capital | 0,5 | 0,1 | 0 | -66,1 |
Operating profit (EBIT) | 0,2 | 0,1 | -0 | -166,3 |
Assets | 0,8 | 0,4 | 0,4 | -5,3 |
Net profit (loss) | 0,2 | 0,1 | -0 | -175 |
Cash | 0,5 | 0,3 | 0,2 | -45,9 |
Net income from sale | 3,4 | 3,3 | 4,1 | 24,8 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,3 | 21,9 |
Working assets | 0,8 | 0,4 | 0,2 | -36 |
Other income costs | 0,1 | 0 | 0,1 | 49 623 |
Depreciation | 0,1 | 0,1 | 0,1 | 27,9 |
% | % | % | p.p. | |
Profitability of capital | 49,7 | 45,1 | -99,8 | -144,9 |
Equity capital to total assets | 58,7 | 30,9 | 11 | -19,9 |
Gross profit margin | 7,2 | 1,9 | -1 | -2,9 |
EBITDA Margin | 8,8 | 3,7 | 0,8 | -2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 34 | 31 | 30 | -1 |
Current financial liquidity indicator | 2.3766930103302 | 1.290116786956787 | 0.6903469562530518 | -0,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.